Intravenous anti TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis (Q44360819)
Jump to navigation
Jump to search
scientific article published in December 2002
Language | Label | Description | Also known as |
---|---|---|---|
English | Intravenous anti TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis |
scientific article published in December 2002 |
Statements
1 reference
Intravenous anti TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis (English)
1 reference
Edmund Cauza
1 reference
Karla Cauza
1 reference
Ursula Hanusch-Enserer
1 reference
Mehrdad Etemad
1 reference
Attila Dunky
1 reference
Karam Kostner
1 reference
1 December 2002
1 reference
1 reference
114
1 reference
23-24
1 reference
1004-1007
1 reference
Identifiers
1 reference